Catherine A. Sohn

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Gaithersburg, MD
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Gregory Weaver, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Catherine A. Sohn

Form 4 holding Director

Jazz Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
14,868
Estimated value
$1,771,225
Report date
14 Aug 2023
Price
$119.13
Ownership
Direct
Form 4 holding Director

LANDEC CORP \CA\

Security class
Common Stock
Shares / value
54,069
Estimated value
$563,399
Report date
04 Jun 2022
Price
$10.42
Ownership
Direct
Form 4 holding Director

Rubius Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
25,000
Estimated value
Report date
12 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Axcella Health Inc.

Security class
Stock Option (Right to Buy)
Shares / value
20,000
Estimated value
Report date
19 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

LANDEC CORP \CA\

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
Report date
04 Jun 2022
Price
$7.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Catherine A. Sohn

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .